Donate
Bills

SB 1089: Preventive Treatment Health Care Act.

  • Session Year: 2025-2026
  • House: Senate
  • Latest Version Date: 2026-03-24

Current Status:

In Progress

(2026-04-16: From committee: Do pass and re-refer to Com. on L., P.E. & R. (Ayes 10. Noes 0.) (April 15). Re-referred to Com. on L., P.E. & R.)

Introduced

In Committee

First Chamber

In Committee

Second Chamber

Enacted

Version:

(1)Existing law requires the California Health and Human Services Agency (CHHSA) to enter into partnerships resulting in the production of generic prescription drugs, including at least one form of insulin made available at production and dispensing costs, if one does not already exist in the market. Existing law requires the insulin production partnership to consider guaranteeing priority access to insulin supply for the state.

This bill, the Preventive Treatment Health Care Act, would require the above-described partnerships to also include the production of at least one acquisition of brand name prescription drugs and the acquisition or production of pens, vial injections, pills, and patches of glucagon-like peptide-1 (GLP-1) or semaglutide, GLP-1 receptor agonist (GLP-1RA) (GLP-1RA), glucose-dependent insulinotropic polypeptide plus GLP-1 (GIP+GLP-1) tirzepatide, and future chronic weight disease products made available at production and dispensing costs and to consider guaranteeing priority access to GLP-1 or GLP-1RA semaglutide, GLP-1RA, GIP+GLP-1 tirzepatide, and future chronic weight disease products supply for the state.

(2)Existing law requires the State Department of Health Care Services to negotiate drug discount agreements with drug manufacturers and to encourage manufacturers to maintain private discount drug programs.This bill would authorize an employer with 100 or more employees to negotiate directly with a drug manufacturer to provide a discount for a GLP-1 or GLP-1RA.(3)Existing law sets forth the obligations of an employer in the employment relationship with an employee.This bill would require an employer with 100 or more to offer its employees access to exercise programs, gym memberships, or both, nutrition programs, and coverage for a GLP-1 or GLP-1RA.(4)Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law sets forth specified coverage requirements for plan contracts and insurance policies.This bill would require a large group health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2027, to cover weight loss as a medical condition. The bill would require a health care service plan contract that provides coverage for outpatient prescription drug benefits and is issued, amended, or renewed on or after January 1, 2027, to include coverage for at least one antiobesity medication approved by the United States Food and Drug Administration. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.(5)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.

(2)Existing law authorizes the Board of Administration of the Public Employees Retirement System to contract with carriers to provide health benefit plans and contracts for employees and annuitants. Existing law sets forth specified coverage requirements for these health benefit plans and contracts.

Commencing January 1, 2027, until January 1, 2032, this bill would require a health benefit plan or contract offered to public employees and annuitants to offer optional coverage for weight loss management, including nutritional information and GLP-1 semaglutide, GLP-1RA, GIP+GLP-1 tirzepatide, and future chronic weight disease products as part of one of its health plan options. The bill would specify cost and usage requirements for these covered chronic weight disease management items. The bill would require CHHSA to make chronic weight disease management medications available to state and local government employers, and to determine if chronic weight disease management medications should be made available to all Californians, at the costs for which they are available under a Public Employees Retirement System health benefit plan or contract.

News Coverage:

SB 1089: Preventive Treatment Health Care Act. | Digital Democracy